
Flatiron drives development decisions with integrated clinical and molecular real-world evidence
— Use cases
Flatiron curates the most robust linked multi-omics solution available — a molecular data suite covering standard-of-care and emerging biomarkers across more than a million patients. Research teams around the world use it to develop pan-tumor, pan-biomarker, and pan-lab insights to support broad discovery as well as focused clinical development.
Download PDF

